(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

NANOCONJUGADOS DE OURO COM DOXORRUBICINA DIRECIONADA PARA TERAPIA DE TUMOR

ArquivadaInvention PatentPCT · US2018012882

Application data

Number

112019013469

Type

Invention Patent

Filing

01/09/2018

Publication

01/07/2020

PCT

US2018012882

Progress at the INPI

  1. Filing01/09/18
  2. Publication01/07/20
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 10/29/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

THE CURATORS OF THE UNIVERSITY OF MISSOURI

US

See this company's full portfolio

Inventors

A. Z. (pessoa física)

US

A. U. (pessoa física)

US

R. K. (pessoa física)

US

Technical data

Priority claims

US

62/444,114 · 01/09/2017

Abstract

A presente revelação fornece nanoconjugados de ouro com doxorrubicina que podem ser usados para tratamentos do câncer. A presente revelação fornece métodos para a produção e o uso dos nanoconjugados.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

10/29/2024

RPI 2808

Parecer de pré-exame

#6.23

07/09/2024

RPI 2792

Adição na publicação

#15.35

10/13/2021

RPI 2649

Notificação de entrada na fase nacional - PCT

#1.3

01/07/2020

RPI 2557

Alteração de dados cadastrais

#1.1

07/09/2019

RPI 2531

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.